Kreos Capital

Kreos Capital is Europe's leading provider of growth and venture debt financing to high-growth companies in the technology and healthcare sectors across Europe and Israel. Since pioneering the growth debt model in 1998, Kreos has committed in excess of €7.0 billion across 830+ transactions to more than 640 pan-European and Israeli companies, investing more than €800m per year. The firm provides flexible, non-dilutive debt facilities — without financial covenants, board seats, or personal guarantees — tailored to each company's unique needs, covering every stage of the growth lifecycle from early-stage development through late-stage, pre-IPO, and publicly listed growth funding. Kreos takes both a credit and an equity view of each financing situation, partnering closely with management teams and equity sponsors across the full economic cycle. In technology, the firm invests across fintech, enterprise software, cybersecurity, semiconductors, digital marketing, and AI; in healthcare, it backs drug and treatment development, medical products and devices, and healthtech. Acquired by BlackRock in August 2023, Kreos continues to operate its proven Growth Debt strategy from its offices in London, Stockholm, and Tel Aviv.